These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21506916)

  • 21. Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).
    Ries M
    J Inherit Metab Dis; 2017 May; 40(3):343-356. PubMed ID: 28314976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERT Degrades Gene Therapy for Storage Disorder.
    Markusic DM
    Mol Ther; 2019 Jul; 27(7):1207-1208. PubMed ID: 31202634
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel therapies and future perspectives.
    Scarpa M; Frustaci A
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S109-10. PubMed ID: 20040320
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lysosomal storage diseases in selected clinical cases].
    Banyś A; Ostróżka-Cieślik A; Sarecka-Hujar B
    Wiad Lek; 2016; 69(1):43-7. PubMed ID: 27162295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
    Seregin SS; Amalfitano A
    Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment perspectives for the lysosomal storage diseases.
    Grabowski GA
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):197-211. PubMed ID: 18321157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Genetics and Gene Therapy of Lysosomial Storage Disorders.
    Tuttolomondo A
    Curr Gene Ther; 2018; 18(2):66-67. PubMed ID: 29741137
    [No Abstract]   [Full Text] [Related]  

  • 28. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of gene therapy in canine and feline models of lysosomal storage disorders.
    Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment strategies for lysosomal storage disorders.
    Beck M
    Dev Med Child Neurol; 2018 Jan; 60(1):13-18. PubMed ID: 29090451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword.
    Cohen IJ; Baris H; Mistry PK
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():58. PubMed ID: 24380122
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on treatment of lysosomal storage diseases.
    Bruni S; Loschi L; Incerti C; Gabrielli O; Coppa GV
    Acta Myol; 2007 Jul; 26(1):87-92. PubMed ID: 17915580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal storage disorders: 4 big questions.
    Eisenstein M
    Nature; 2016 Sep; 537(7621):S165. PubMed ID: 27652787
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzyme replacement therapy for lysosomal storage diseases.
    Ohashi T
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic approaches for lysosomal storage diseases: a patent update.
    Urbanelli L; Sagini K; Polidoro M; Brozzi A; Magini A; Emiliani C
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Therapies for Lysosomal Storage Diseases.
    Gabig-Cimińska M; Jakóbkiewicz-Banecka J; Malinowska M; Kloska A; Piotrowska E; Chmielarz I; Moskot M; Węgrzyn A; Węgrzyn G
    Curr Mol Med; 2015; 15(8):746-71. PubMed ID: 26391547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment options for lysosomal storage disorders: developing insights.
    van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ
    Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory watch: enhanced chance of success for protein replacement therapies.
    Crunkhorn S
    Nat Rev Drug Discov; 2013 Jun; 12(6):414. PubMed ID: 23722335
    [No Abstract]   [Full Text] [Related]  

  • 39. Emerging therapies for neuropathic lysosomal storage disorders.
    Kelly JM; Bradbury A; Martin DR; Byrne ME
    Prog Neurobiol; 2017 May; 152():166-180. PubMed ID: 27725193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases.
    Huang HP; Chuang CY; Kuo HC
    Stem Cell Res Ther; 2012 Aug; 3(4):34. PubMed ID: 22925465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.